Zhimeng Biopharma EN | 简体
Zhimeng Biopharma
  • Home
  • About Us
  • People
    • Leadership Team
    • Scientific Advisors
  • Pipeline
  • News
  • Investors
  • Join Us
  • Contact

People

Scientific Advisors

Fabien Zoulim, M.D., Ph.D. (Honorary Position)

Fabien Zoulim, M.D., Ph.D. (Honorary Position)

Pei-Jer Chen, MD, Ph.D. (Honorary Position)

Pei-Jer Chen, MD, Ph.D. (Honorary Position)

Kewei Wang, M.D., Ph.D. (Honorary Position)

Kewei Wang, M.D., Ph.D. (Honorary Position)

Get in touch

Contact Us About Us Leadership Team Scientific Advisors
Quick Links
  • About Us
  • Contact Us
  • Join Us
  • Pipeline
  • Leadership Team
  • Scientific Advisors
Recent News
  • Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial
  • Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase I Clinical Trial of CB06
  • Zhimeng Biopharma Announces FDA Approval of its Investigational New Drug (IND) Application for CB06-036
  • News Release from Shanghai Zhimeng Biopharma, Inc

© 2022 Zhimeng Biopharma. All Rights Reserved. 备案号:沪ICP备18045542号-1 | 沪公网安备 31011502011190号

© 2022 Zhimeng Biopharma. All Rights Reserved.